DRGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 7 of 9 cases where DRGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 78%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DRGN's RSI Oscillator exited the oversold zone, 3 of 6 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 11 of 17 cases where DRGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for DRGN just turned positive on November 04, 2026. Looking at past instances where DRGN's MACD turned positive, the stock continued to rise in 9 of 12 cases over the following month. The odds of a continued upward trend are 75%.
Following a +2.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where DRGN advanced for three days, in 47 of 61 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for DRGN entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
ECX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 06, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 38 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECX as a result. In 68 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
ECX moved below its 50-day moving average on November 03, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for ECX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ECX's RSI Oscillator exited the oversold zone, 22 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 46 cases where ECX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +13.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECX advanced for three days, in 157 of 185 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
ECX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.189) is normal, around the industry mean (0.781). P/E Ratio (-13.357) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.418) is also within normal values, averaging (49.456).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. ECX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
| DRGN | ECX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 50% | 3 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 65% | 2 days ago 83% |
| Momentum ODDS (%) | N/A | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 75% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 88% |
| Advances ODDS (%) | 24 days ago 77% | 7 days ago 85% |
| Declines ODDS (%) | 7 days ago 88% | 3 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 81% |
A.I.dvisor tells us that DRGN and TUYA have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRGN and TUYA's prices will move in lockstep.
| Ticker / NAME | Correlation To DRGN | 1D Price Change % | ||
|---|---|---|---|---|
| DRGN | 100% | +1.73% | ||
| TUYA - DRGN | 18% Poorly correlated | +0.61% | ||
| ECX - DRGN | 4% Poorly correlated | +1.30% | ||
| KC - DRGN | -11% Poorly correlated | +1.43% |
A.I.dvisor tells us that ECX and APTV have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECX and APTV's prices will move in lockstep.
| Ticker / NAME | Correlation To ECX | 1D Price Change % | ||
|---|---|---|---|---|
| ECX | 100% | +1.30% | ||
| APTV - ECX | 23% Poorly correlated | -0.40% | ||
| ALV - ECX | 22% Poorly correlated | +0.36% | ||
| CAAS - ECX | 22% Poorly correlated | +7.30% | ||
| MBLY - ECX | 20% Poorly correlated | +2.66% | ||
| SYPR - ECX | 20% Poorly correlated | +0.83% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ROBT | 55.27 | 0.81 | +1.49% |
| First Trust Nasdaq Artificial Intelligence & Robotics ETF (ROBT) | |||
| PRCS | 29.26 | 0.14 | +0.48% |
| Parnassus Core Select ETF | |||
| QLVD | 35.31 | N/A | N/A |
| Northern Trust Developed Markets ex-US Quality Low Volatility ETF (QLVD) | |||
| SCHZ | 22.40 | -0.01 | -0.04% |
| Schwab US Aggregate Bond ETF (SCHZ) | |||
| PEX | 23.38 | -0.09 | -0.40% |
| ProShares Global Listed Private Equity ETF (PEX) | |||